NewsbenzingaBioLine Rx Q2 Sales $294.000K Miss $500.000K EstimateAug 31, 2026, 07:01 ET · PublishedSummaryOriginalView sourceArticle summaryPlease check the source for details.An excerpt from the original article.Related companiesBLRXBLRXView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…